Treatment

Displaying 51 - 60 of 374

Towards personalised treatment for lung cancer

Towards personalised treatment for lung cancer
Research aims to identify and characterise resistant lung cancer stem cells, and develop a model to customise drugs that can eradicate all cancer cells of an individual patient. This is the goal of researcher Mattias Magnusson, who received SEK 6 million from the Sjöberg Foundation to conduct this research project. Every year, close to 4 000 people in Sweden develop lung cancer. It is the fifth most common form of cancer in the country and the prognosis of lung cancer is worse than for many other cancer forms.
13th December 2017

Video game system helps physical therapists

Video game system helps physical therapists
Motion-based lab technology can help physical therapists, clinicians and athletic trainers analyse how we move—it also is very expensive. Some motion labs can cost upward of $100,000. Now, a team of University of Missouri researchers is finding that the depth camera often associated with video game systems can provide a variety of health care providers with objective information to improve patient care.
11th December 2017

Drug could slow progress of Huntington's disease

Drug could slow progress of Huntington's disease
The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human trial, and successfully lowered the level of the harmful huntingtin protein in the nervous system. After over a decade in pre-clinical development, this first human trial of huntingtin-lowering drug began in late 2015, led by Professor Sarah Tabrizi (UCL Institute of Neurology) and sponsored by Ionis Pharmaceuticals.
11th December 2017


Portable gel could save an injured eye

Portable gel could save an injured eye
When a soldier sustains a traumatic eye injury on the battlefield, any delay in treatment may lead to permanent vision loss. With medical facilities potentially far away and no existing tools to prevent deterioration, medics are in a high-stakes race against the clock. A multidisciplinary team of scientists and engineers at USC are close to solving the problem. They have developed a reversible, temperature-sensitive temporary seal that changes from a fluid to a super-strong semi-solid when applied to the eye.
11th December 2017

Orthopaedic product has the potential to improve bone apposition

Orthopaedic product has the potential to improve bone apposition
  Omnia Medical VBR has been granted the first US FDA 510(k) clearance for a vertebral body replacement (VBR) system manufactured from PEEK-OPTIMA HA Enhanced polymer, from Invibio Biomaterial Solutions, for use in the thoracolumbar spine to replace a collapsed, damaged, or unstable vertebral body.
8th December 2017

Method could be used in targeted cancer therapeutics

Inspired by white blood cells rolling on endovascular walls before transmigrating to the disease site, scientists at ETH Zurich have succeeded in getting particles to move along the walls of microscopic, three-dimensional vessels. This method could be used in targeted cancer therapeutics. When white blood cells are summoned to combat invasive bacteria, they move along blood vessels in a specific fashion, i.e., like a ball propelled by the wind, they roll along the vascular wall to reach their point of deployment.
29th November 2017

PanDrugs: genomic data analysis to better treat cancer

PanDrugs: genomic data analysis to better treat cancer
Cancer genomics analysis is a promising approach to predict drug response and outcome. With PanDrugs, the PERSMEDOMICS project provides an innovative bioinformatics methodology to guide the selection of therapies based on individual patients’ genomic profile. PanDrugs is one of the missing links between the potential of biomarkers as predictive tools for treatment outcome and their actual use in clinical settings.
28th November 2017

InterAtrial shunt device shows promise in diastolic heart failure

InterAtrial shunt device shows promise in diastolic heart failure
Results presented at the American Heart Association Scientific Sessions and published in Circulation show that a new device designed to treat diastolic heart failure is safe and effective. The first patient in the randomised, blinded study was enrolled at The Ohio State University Ross Heart Hospital, which also enrolled the most patients in the trial. Diastolic heart failure (DHF) occurs when the heart muscle becomes stiff and doesn’t relax enough to allow blood to flow from the lungs into the heart.
27th November 2017

Medical grade TPE for eye drop packaging

Medical grade TPE for eye drop packaging
With several functional components manufactured using a newly developed, medical grade TPE from KRAIBURG TPE, Aptar Pharma launched its ophthalmic squeeze dispenser (OSD). The Thermoplastic Elastomer components come into direct contact with the medical eye drop formulation. Aptar Pharma requires classification as a medical grade plastic in compliance with the stringent regulations for the primary packaging of sensitive medications.
23rd November 2017

Video game improves balance in children with autism

Video game improves balance in children with autism
  Playing a video game that rewards participants for holding various 'ninja' poses could help children and youth with autism spectrum disorder (ASD) improve their balance, according to a recent study in the Journal of Autism and Developmental Disorders led by researchers at the University of Wisconsin–Madison.
22nd November 2017


Treatment documents


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

Medical Japan 2018
21st February 2018
Japan INTEX Osaka
Med-Tech Innovation Expo 2018
25th April 2018
United Kingdom Ricoh Arena, Coventry